Ulinastatin Is a Novel Protease Inhibitor and Neutral Protease Activator
- 1 March 2008
- journal article
- Published by Elsevier BV in Transplantation Proceedings
- Vol. 40 (2), 387-389
- https://doi.org/10.1016/j.transproceed.2008.01.034
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Bikunin (Urinary Trypsin Inhibitor): Structure, Biological Relevance, And MeasurementPublished by Elsevier BV ,2007
- Adjustment of digestion enzyme composition improves islet isolation outcome from marginal grade human donor pancreataCell and Tissue Banking, 2006
- International Trial of the Edmonton Protocol for Islet TransplantationThe New England Journal of Medicine, 2006
- Modified Two-Layer Preservation Method (M-Kyoto/PFC) Improves Islet Yields in Islet IsolationAmerican Journal of Transplantation, 2006
- Five-Year Follow-Up After Clinical Islet TransplantationDiabetes, 2005
- Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: A randomized, controlled trialClinical Gastroenterology and Hepatology, 2005
- Optimization of neutral protease to collagenase activity ratio for islet of langerhans isolationTransplantation Proceedings, 2004
- Endogenous pancreatic enzyme activity levels show no significant effect on human islet isolation yield.Cell Transplantation, 2004
- SERINE-PROTEASE INHIBITION DURING ISLET ISOLATION INCREASES ISLET YIELD FROM HUMAN PANCREASES WITH PROLONGED ISCHEMIA1Transplantation, 2001
- Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive RegimenThe New England Journal of Medicine, 2000